Close Menu

NEW YORK (360Dx) – Laboratory Corporation of America announced today that it will acquire specialty contract research organization Chiltern for roughly $1.2 billion in cash.

According to LabCorp, Chiltern brings a strong presence among emerging-to-mid biopharma customers, as well as expertise in early-stage drug development, medical device development, and oncology. It also offers robust functional service provider (FSP) solutions and an endpoint suite of interactive response technology.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.